Recipe for a new imaging biomarker: carefully combine target, reagent, and technology.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 22205431.
- Also identified by DOI 10.1038/ki.2011.374 and PMC identifier 6364693.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A careful combination of biological targeting moieties (C3 fragments), imaging reagents (a small particle of iron oxide), and appropriate technology (T2-weighted magnetic resonance imaging) is the key to the successful development of an imaging agent for glomerulonephritis. This recipe applies to virtually any molecular imaging probe for the kidney and throughout the body. However, each organ and disease requires a unique combination of these three components in order to achieve success.
Medical subject headings
- Complement C3b
- Contrast Media
- Lupus Nephritis
- Magnetic Resonance Imaging
- Magnetite Nanoparticles